NM_000110.4(DPYD):c.1896T>C (p.Phe632=) AND capecitabine response - Toxicity
- Germline classification:
- drug response (1 submission)
- Last evaluated:
- Mar 24, 2021
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001787905.2
Allele description [Variation Report for NM_000110.4(DPYD):c.1896T>C (p.Phe632=)]
NM_000110.4(DPYD):c.1896T>C (p.Phe632=)
Condition(s)
- Name:
- capecitabine response - Toxicity
- Identifiers:
-
Mus musculus aspartate beta-hydroxylase domain containing 2 (Asphd2), transcript...
Mus musculus aspartate beta-hydroxylase domain containing 2 (Asphd2), transcript variant 5, mRNAgi|1257171116|ref|NM_001357014.1|Nucleotide
-
Mus musculus retention in endoplasmic reticulum sorting receptor 1 (Rer1), mRNA
Mus musculus retention in endoplasmic reticulum sorting receptor 1 (Rer1), mRNAgi|13385881|ref|NM_026395.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: May 7, 2024